Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial

Saved in:
Bibliographic Details
Published in:Blood cancer journal (New York) 2023-01, Vol.13 (1), p.10-4, Article 10
Main Authors: Zu, Yingling, Gui, Ruirui, Li, Zhen, Wang, Juan, Zhang, Yanli, Yu, Fengkuan, Zhao, Huifang, Zhan, Xinrong, Wang, Zhongliang, Xing, Pengtao, Wang, Xianjing, Wang, Huili, Song, Yongping, Zhou, Jian
Format: Article
Language:English
Subjects:
13/100
631/532/1542
631/67/580/1884
Antilymphocyte Serum - therapeutic use
Biomedical and Life Sciences
Biomedicine
Cancer Research
Correspondence
Cyclophosphamide - therapeutic use
Graft vs Host Disease - etiology
Graft vs Host Disease - prevention & control
Hematologic Neoplasms - drug therapy
Hematology
Hematopoietic Stem Cell Transplantation - adverse effects
Humans
Oncology
Prospective Studies
Retrospective Studies
Transplantation Conditioning
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2044-5385
2044-5385
DOI:10.1038/s41408-022-00771-w